Literature DB >> 7058857

Maternal phenylketonuria--results of dietary therapy.

R R Lenke, H L Levy.   

Abstract

Untreated maternal phenylketonuria (PKU) may result in nonphenylketonuric offspring with mental retardation, microcephaly, congenital heart disease, and low birth weight. We obtained information about 34 pregnancies in which dietary therapy was instituted to lower the concentration of phenylalanine in maternal blood in an attempt to avoid fetal damage. The outcomes varied from mental normality with no evidence of fetal effect to neonatal death due to congenital heart disease. Dietary therapy with control of the maternal biochemical abnormalities is not yet of proved efficacy in preventing these fetal effects. The available data tend to support initiation of dietary therapy prior to conception for best results, but the number of cases is small and points to the need for further research.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058857     DOI: 10.1016/0002-9378(82)90759-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Maternal phenylketonuria.

Authors:  R Koch; E G Friedman; E Wenz; K Jew; C Crowley; G Donnell
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Group work with adolescent PKU girls and their mothers.

Authors:  B E Cohen; R Weiss; R Hadar; M Normand; S Shiloh; D Elhanati
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

3.  Maternal PKU: control of an emerging problem.

Authors:  H L Levy
Journal:  Am J Public Health       Date:  1982-12       Impact factor: 9.308

4.  Maternal Phenylketonuria (MPKU).

Authors:  W E Schoonheyt; W B Hanley; J T Clarke; V Austin; D A Howe
Journal:  Can Fam Physician       Date:  1986-10       Impact factor: 3.275

5.  A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada.

Authors:  R Koch; W Hanley; H Levy; R Matalon; B Rouse; F Dela Cruz; C Azen; E Gross Friedman
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  Maternal phenylketonuria: comparison of two treated full term pregnancies.

Authors:  R P Soeters; R C Sengers; P W van Dongen; J M Trijbels; T K Eskes
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

7.  The use of gelatin capsules for ingestion of formula in dietary treatment of maternal phenylketonuria.

Authors:  H H Kecskemethy; D Lobbregt; H L Levy
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations.

Authors:  S E Waisbren; B D Hamilton; P J St James; S Shiloh; H L Levy
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

9.  A psychosocial model of a medical problem: Maternal phenylketonuria.

Authors:  S Shiloh; S E Waisbren; H L Levy
Journal:  J Prim Prev       Date:  1989-09

10.  Mouse models of human phenylketonuria.

Authors:  A Shedlovsky; J D McDonald; D Symula; W F Dove
Journal:  Genetics       Date:  1993-08       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.